Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Owada S, Endo H, Okada C, Yoshida K, et al. Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer. Anticancer Res 2020;40:5071-5079.
PMID: 32878795


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016